Is Hepatitis C a luxury?
Interferon Alfa-2B and Rivavirma, both produced in Cuba, are components of Heberviron. The drugt is used not only to combat the causative virus of Hepatitis C in blood but, in the long range, eliminates lesions in the liver and totally cures the disease.
The components of Heberviron were developed and are being produced by Cuba: the Interferon by the CIGB and the Center of Bio-products, and the Ribavirina by the Medicament Research and Development Center and Novatec Laboratories, which demonstrates the integration and cooperation of the institutions in the Scientific Complex.
In the meanwhile, Novartis AG says that it has signed an exclusive worldwide agreement with US biopharmaceuticals company Human Genome Sciences to acquire rights to hepatitis C drug Albuferon.
The investigational drug is expected to enter Phase III clinical trials by the end of 2006, Novartis said.
Under the terms of the agreement, Novartis will make an upfront payment of 45 mln usd, with milestones payable at specific stages of development and sales milestones payable following the drug''s launch.
Novartis and HGS will co-promote Albuferon (albumin interferon alfa-2b) in the US, while Novartis will have exclusive rights to market and promote it in the rest of the world.
The Novartis drug has an albumin prefixed to interferon alfa-2b, which even the Cubans have developed successfully in the fight against the dreadful Hep C Virus.
The western media has been harping about the massive market potential of the new drugs because of the 170 million people infected with HCV. Stocks has been rising and plunging with every detail made available of the research on HCV drugs... it is a scary secnario!
If companies are going to make a fortune out of the misfortune of 170 million people and their families, and if more people in different stock markets around the world are going to speculate and gamble on the stock value of these pharma companies it would only help the rich get richer and meaner.
Out of the 170 Million infected people, how many can actually afford a health insurance or even afford to pay for basic neccessities is something no one has really cared to ask.
Was it the MARKET that determined how we fought against Small Pox, Plague etc?
Anyone who buys a Novartis or Vertex share to make profits out of a HEP C patient is accumulating bad Karma score.
When it comes to medicare and education in a country -- the real profit to that country is a Healthy and Educated population. Outrageous Monetary Profits, by squeezing the ones who want to live without illness and the young ones who want to gain knowledge, is simply unacceptable.
HCV (Hepatitis) is not a luxury that one has to pay for, it is a misfortune that could knock on our doors too.
If the Cubans have got it right and if the drug is working... Thank You Cuba. Wish I could go to Cuba and check it out myself.
The components of Heberviron were developed and are being produced by Cuba: the Interferon by the CIGB and the Center of Bio-products, and the Ribavirina by the Medicament Research and Development Center and Novatec Laboratories, which demonstrates the integration and cooperation of the institutions in the Scientific Complex.
In the meanwhile, Novartis AG says that it has signed an exclusive worldwide agreement with US biopharmaceuticals company Human Genome Sciences to acquire rights to hepatitis C drug Albuferon.
The investigational drug is expected to enter Phase III clinical trials by the end of 2006, Novartis said.
Under the terms of the agreement, Novartis will make an upfront payment of 45 mln usd, with milestones payable at specific stages of development and sales milestones payable following the drug''s launch.
Novartis and HGS will co-promote Albuferon (albumin interferon alfa-2b) in the US, while Novartis will have exclusive rights to market and promote it in the rest of the world.
The Novartis drug has an albumin prefixed to interferon alfa-2b, which even the Cubans have developed successfully in the fight against the dreadful Hep C Virus.
The western media has been harping about the massive market potential of the new drugs because of the 170 million people infected with HCV. Stocks has been rising and plunging with every detail made available of the research on HCV drugs... it is a scary secnario!
If companies are going to make a fortune out of the misfortune of 170 million people and their families, and if more people in different stock markets around the world are going to speculate and gamble on the stock value of these pharma companies it would only help the rich get richer and meaner.
Out of the 170 Million infected people, how many can actually afford a health insurance or even afford to pay for basic neccessities is something no one has really cared to ask.
Was it the MARKET that determined how we fought against Small Pox, Plague etc?
Anyone who buys a Novartis or Vertex share to make profits out of a HEP C patient is accumulating bad Karma score.
When it comes to medicare and education in a country -- the real profit to that country is a Healthy and Educated population. Outrageous Monetary Profits, by squeezing the ones who want to live without illness and the young ones who want to gain knowledge, is simply unacceptable.
HCV (Hepatitis) is not a luxury that one has to pay for, it is a misfortune that could knock on our doors too.
If the Cubans have got it right and if the drug is working... Thank You Cuba. Wish I could go to Cuba and check it out myself.
0 comments:
Post a Comment